McKesson Europe AG (McKesson Europe AG) EBIT per Share : $-0.02 (TTM As of Mar. 2022)

View and export this data going back to 2008. Start your Free Trial

What is McKesson Europe AG EBIT per Share?

McKesson Europe AG's EBIT per Share for the six months ended in Mar. 2022 was $-0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for McKesson Europe AG's EBIT per Share or its related term are showing as below:

CAKFY's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Distribution industry.
Industry Median: 6.9
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

McKesson Europe AG's EBIT for the six months ended in Mar. 2022 was $-22 Mil.

McKesson Europe AG EBIT per Share Historical Data

The historical data trend for McKesson Europe AG's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG EBIT per Share Chart

McKesson Europe AG Annual Data

Trend

Dec12

Dec13

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

EBIT per Share

Get a 7-Day Free Trial

-0.31

0.05

0.02

0.04

-0.02

McKesson Europe AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22
EBIT per Share	Get a 7-Day Free Trial															-0.31	0.05	0.02	0.04	-0.02

McKesson Europe AG EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

McKesson Europe AG's EBIT per Share for the fiscal year that ended in Mar. 2022 is calculated as

	EBIT per Share		(A: Mar. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-21.586	/	1016.105
=	-0.02

McKesson Europe AG's EBIT per Share for the quarter that ended in Mar. 2022 is calculated as

	EBIT per Share		(Q: Mar. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-21.586	/	1016.105
=	-0.02

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.02

McKesson Europe AG (OTCPK:CAKFY) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

McKesson Europe AG EBIT per Share Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

McKesson Europe AG (McKesson Europe AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (OTCPK:CAKFY) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Stockholmer Platz 1, Stuttgart, BW, DEU, 70137

Website

https://www.mckesson.eu

McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (McKesson Europe AG) Headlines

No Headlines